Takara Bio offers hiPSC-derived cells and other stem cell and cell biology research products that can support your efforts to study SARS-CoV-2 infection, identify potential targets for drug discovery, evaluate the metabolism and safety of candidate drugs, and develop therapeutic approaches to treat COVID-19.
With our expertise in hiPSC culture and differentiation, we are able to provide functional, mature hiPSC-based models for studying viral transmission and infection in the heart, liver, pancreas, and intestinal epithelium. Our kits provide a renewable source of hiPSC-derived cells and address several limitations of the current gold-standard models, such as rapid loss of functionality, limited availability, interdonor variability of primary cells, and inability of immortalized cell lines to accurately reflect in vivo cell function. Our relevant, reliable cell culture systems, along with our Cellartis Power Primary HEP Medium for long-term culture of primary hepatocytes, are also ideal for evaluating the metabolism and toxicity of drug candidates.
For therapeutic research applications, we provide a mesenchymal stem cell culture medium that promotes efficient maintenance and expansion of mesenchymal stem cells from bone marrow, adipose tissue, or umbilical cord. Also, we provide an unparalleled extracellular vesicle isolation kit for studying the potential involvement of these vesicles in infection and for the development of potential therapeutic strategies.
Explore our stem cell solutions for COVID-19 drug discovery research:
Learn about our complete culture systems, including hiPSC-derived hepatocytes, beta cells, cardiomyocytes, and intestinal epithelial cells, for understanding viral infection and transmission mechanisms as well as identifying novel methods for blocking COVID-19 progression.
Learn about our functional and mature hiPSC-derived hepatocytes and cardiomyocytes—plus our breakthrough long-term primary hepatocyte culture medium—for evaluating the absorption, distribution, metabolism, excretion, and toxicity (ADME-Tox) of candidate COVID-19 drugs.
Learn about our xeno-free human mesenchymal stem cell culture medium and extracellular vesicle purification kits that support the efforts of researchers developing COVID-19 therapies.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2020 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.